Cargando…
Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis
The use of TNF-α inhibitors for the treatment of moderate to severe psoriasis and psoriatic arthritis is increasingly more frequent. The authors report a case of Guillain-Barré syndrome as a late manifestation of the treatment with adalimumab. Although unusual, this is relevant for professionals who...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Dermatologia
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726687/ https://www.ncbi.nlm.nih.gov/pubmed/29267456 http://dx.doi.org/10.1590/abd1806-4841.20175871 |